Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-032727
Filing Date
2025-06-23
Accepted
2025-06-23 20:40:41
Documents
1
Period of Report
2025-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1750725635.html 4  
1 FORM 4 wk-form4_1750725635.xml 4 7931
  Complete submission text file 0001628280-25-032727.txt   9389
Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address
MOTT DAVID M (Reporting) CIK: 0001219871 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36485 | Film No.: 251066419

Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Issuer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)